Table 2 Tissue caveolin-1 expression in prostate cancer and benign prostatic hyperplasia
From: Expression and clinical significance of Caveolin-1 in prostate Cancer after transurethral surgery
Cases | Positive | Negative | Positive rate | X2 | P value | |
|---|---|---|---|---|---|---|
Prostate cancer | 47 | 29 | 18 | 61.70% | 15.085 | 0.000 |
Benign prostatic hyperplasia | 20 | 2 | 18 | 10% |